VERTEX PHARMACEUTICALS INC (VRTX) Institutional Ownership Changes & 13F Activity

VERTEX PHARMACEUTICALS INC (VRTX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Sequoia Financial Advisors, Tweedy, Browne Co All Funds (US), Torray Fund, and ARK Invest.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCSell-83,360421,688$188,300,560
Q1 2026Sequoia Financial AdvisorsBuy1,30214,898$6,652,671
Q1 2026Tweedy, Browne Co All Funds (US)Buy1,23940,387$18,034,411
Q1 2026Torray FundSell-8015,386$6,870,464
Q4 2025Renaissance Technologies LLCSell-230,840505,048$228,968,561
Q4 2025Torray FundSell-78915,466$7,011,666
Q4 2025ARK InvestBuy43526,100$11,832,537
Q4 2025Sequoia Financial AdvisorsSell-38413,596$6,163,898
Q4 2025Tweedy, Browne Co All Funds (US)Buy8339,148$17,748,137
Q3 2025Renaissance Technologies LLCSell-269,000735,888$288,203,176
Q3 2025Parnassus Endeavor FundSell-63,0071,648,433$645,592,300
Q3 2025Tweedy, Browne Co All Funds (US)Buy1,81239,065$15,299,417
Q3 2025ARK InvestBuy1,60225,665$10,051,390
Q3 2025Torray FundSell-62416,255$6,366,108
Q3 2025Sequoia Financial AdvisorsSell-39313,980$5,475,119
Q2 2025Renaissance Technologies LLCSell-166,6831,004,888$447,376,138
Q2 2025Parnassus Endeavor FundSell-61,2781,711,440$761,933,088
Q2 2025ARK InvestSell-2,28124,063$10,712,990
Q2 2025Torray FundBuy1,15816,879$7,514,531
Q2 2025Tweedy, Browne Co All Funds (US)Sell-1,06337,253$16,585,036
Q2 2025Sequoia Financial AdvisorsBuy44214,373$6,398,641
Q1 2025Renaissance Technologies LLCSell-225,6381,171,571$568,001,052
Q1 2025Parnassus Endeavor FundSell-43,2321,772,718$859,449,141
Q1 2025Tweedy, Browne Co All Funds (US)Sell-2,31538,316$18,576,363
Q1 2025Sequoia Financial AdvisorsBuy1,04113,931$6,753,866
Q1 2025ARK InvestBuy99426,344$12,772,279
Q1 2025Torray FundSell-28715,721$7,621,855
Q4 2024Parnassus Endeavor FundBuy1,815,2121,815,950$731,283,065
Q4 2024Renaissance Technologies LLCSell-234,2841,397,209$562,656,064
Q4 2024ARK InvestSell-25,74925,350$10,208,544

Frequently asked questions about VRTX activity

  • Which institutional owners are buying VRTX?

    Institutional owners buying VRTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in VRTX activity?

    "Buy" means an investor increased their reported position in VRTX compared to the prior reporting period. This reflects growing exposure to VERTEX PHARMACEUTICALS INC (VRTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in VRTX increasing?

    Institutional interest in VRTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related VRTX Institutional Insights